Coronary artery disease
A long-term heart condition in which fatty deposits narrow the arteries that feed the heart. It can cause chest pain and breathlessness during activity, but some people have no signs until a heart attack. It cannot be cured, but lifestyle changes, medicines and procedures can ease the symptoms and lower the risk of a heart attack. The risk rises with age, and men tend to get it earlier than women.
Read more about coronary artery diseaseTrial-stage treatments and research studies you can joinOpen trials for referral
Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.
Filters
- Tests clazakizumab in adults with kidney failure on dialysis
Tests clazakizumab against placebo in dialysis patients with heart disease or diabetes and inflammation.
Alexandroupoli, GreeceAlso Arta, Athens, Ioannina, Larissa, Marousi, Ptolemaida, Rio, ThessalonikiAge 18+ - Tests regadenoson safety in children with heart artery disease
Tests regadenoson, a heart stress drug, in children and teens with heart disease.
Athens, GreeceAge 0 to 18 - Compares two heart-bypass machine methods during heart surgery in adults
Compares a minimally invasive bypass circuit with standard bypass in adults having heart surgery.
Thessaloniki, GreeceAge 18 to 85 - Compares two heart-rhythm drugs for irregular heartbeat in emergency care
Tests flecainide against amiodarone to restore rhythm in people with heart artery disease.
Athens, GreeceAlso Nea IoniaAge 18 to 85 - Tracks safety and effectiveness of Medtronic products on the market
Follows people treated with Medtronic devices for heart rhythm, brain, bladder and digestive conditions.
Athens, GreeceAlso Marousi, Thessaloniki - Registry Tracking Procedures to Open Fully Blocked Heart Arteries
Records treatments and results for people with fully blocked heart arteries.
Athens, Greece - Empagliflozin and arteries and heart function after a heart attack in type 2 diabetes
Tests empagliflozin in adults with type 2 diabetes after a heart attack.
Athens, GreeceAge 18 to 80 - Studies whether artery flow tests can predict outcomes in acute coronary syndromes
Observes heart attack patients using artery flow, heart ultrasound and blood tests.
Thessaloniki, GreeceAge 18 to 85 - Ulnar artery access for heart procedures when the radial artery is blocked
Studies ulnar artery access in adults with a blocked radial artery.
Athens, GreeceAge 18+ - Heart and metabolic problems in people with hormone-silent pheochromocytoma and paraganglioma
Looks at heart and metabolic complications before and after surgery in adults with these tumors.
Athens, GreeceAge 18+ - Landiolol and heart attack damage size in people with STEMI
Compares landiolol with usual beta-blocker tablets on heart damage after STEMI.
Thessaloniki, GreeceAge 18 to 80 - Blood Tryptase Levels in People With Stable Coronary Artery Disease
Measures tryptase in blood to see how it relates to heart artery disease.
Athens, GreeceAlso LarissaAge 18 to 85 - Tests heart ultrasound stress results against later coronary angiography findings
Follows adults with coronary artery disease whose stress echocardiography showed heart ischemia.
Athens, GreeceAge 18 to 100 - Registry Following Patients with Calcified Heart Artery Blockages Treated with Lithotripsy Balloon
Records how a lithotripsy device is used to open hardened coronary artery blockages in adults.
Athens, GreeceAge 18+ - Registry following people who have heart artery testing for microvascular disease
Records heart artery pressure and flow tests in adults with suspected coronary disease.
Athens, GreeceAlso Heraklion, PátraiAge 18+ - Tests early heart testing to guide defibrillator implants after heart attack
Tests early heart testing to guide defibrillators in weak-heart patients after heart attack.
Athens, GreeceAlso HeraklionAge 18 to 85 - Observing patients with serious heart conditions in a cardiac intensive care unit
Follows adults with acute heart conditions admitted to a cardiac intensive care unit.
Ioannina, Greece - Tests a personalized prevention program in people with stable heart disease at high risk
Tests a personalized prevention program in adults with stable coronary heart disease and high risk.
Athens, GreeceAge 30 to 80
Trials that have ended are not listed here, because nobody can join them. Stopped and finished Coronary artery disease trials (research view)
Take part in research
14 official research programmes take people with this disease. In a biobank or a registry you give a blood or tissue sample, or your health data, for many research teams to use.
See the research programmesSearch the publications
The results open on the publications page in a new tab, so this page stays as it is.
Lists with this disease filtered
Where treatment stands
There is no cure for coronary artery disease, but treatment can help manage the symptoms and lower the chance of problems such as heart attacks.
Approved: 71
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 31
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 5
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.
Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 46 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for coronary artery disease. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. EU approvals newer than that data come from the European Commission’s Union Register, checked on 17 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in Greece, for you and your family.
Coronary artery disease organisations in Greece
- Ελληνικό Ίδρυμα Καρδιολογίας (ΕΛΙΚΑΡ)
Greek national heart foundation working on prevention of cardiovascular disease and public information; member of the European Heart Network.
General support in Greece
- Κλίμακα – Γραμμή Παρέμβασης για την Αυτοκτονία 1018
Nationwide 24/7 suicide prevention helpline 1018 run by the NGO Klimaka under the auspices of the Greek Ministry of Health.
International organisations
Frontlight Community
Coronary artery disease community in Greece
People living with coronary artery disease and those close to them share what they went through. Posts are not medical advice: ask your doctor about your own treatment.
You need a Frontlight account with a verified e-mail address to comment.
Offer tissue or data
There are three ways to help research move faster.
Approved treatments
75 medicines are approved for coronary artery disease in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.
Approvals not in this list yet
Found for coronary artery disease in the regulators' official registers; the list below does not show these approvals yet. We read these registers every day.
- REPATHAevolocumab
ApprovedNew use approved in the US by the FDA on 9 Oct 2026; the FDA label names this disease.
Approved for:
Label (FDA, on DailyMed) ›To reduce the risk of major adverse cardiovascular (CV) events (CV death, myocardial infarction, stroke, unstable angina requiring hospitalization, coronary revascularization, or any ischemia-driven arterial revascularization) in adults at increased risk for these events.
- KERENDIAfinerenone
ApprovedNew use approved in the US by the FDA on 16 Sept 2026; the FDA label names this disease.
Approved for:
Label (FDA, on DailyMed) ›Kerendia is indicated to: reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with Type 2 diabetes mellitus (T2DM) …
- WEGOVYsemaglutide
ApprovedNew use approved in the US by the FDA on 19 Mar 2026; the FDA label names this disease.
Approved for:
Label (FDA, on DailyMed) ›to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight.
Checked on 18 Nov 2026 in the official lists of the US (FDA), the EU (European Commission and EMA) and Switzerland (Swissmedic), which we read every day. The lists of Japan (PMDA, approvals since April 2004), France (ANSM, medicines approved in France only) and Taiwan (TFDA) were checked on 11 Nov 2026. For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 24 uncertain matches are left out. Other countries' own approvals were not checked.
“Miracle cure” fact checker
Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
About coronary artery disease
Sources: NHS, MedlinePlus
A long-term heart condition in which fatty deposits narrow the arteries that feed the heart. It can cause chest pain and breathlessness during activity, but some people have no signs until a heart attack. It cannot be cured, but lifestyle changes, medicines and procedures can ease the symptoms and lower the risk of a heart attack. The risk rises with age, and men tend to get it earlier than women.
What is it?
The coronary arteries carry blood and oxygen to the heart muscle. Over the years, fatty deposits containing cholesterol build up inside their walls (atherosclerosis). The arteries narrow, so the heart gets less blood than it needs, and a blockage can cause a heart attack. In some people, the heart's tiny blood vessels are damaged instead; this type is more common in women.
It is the most common type of heart disease in the United States and a leading cause of death for both men and women. The risk rises with age, and men tend to get it earlier. Smoking, high blood pressure, high cholesterol, diabetes, obesity and too little activity raise the risk. It runs in families: the risk is higher if a parent, brother or sister had heart disease before 50.
The first signs
Some people have no signs, and only find out when they have a heart attack. Signs may start or get worse when you are active or under stress, and may go away with rest.
- chest pain, pressure or tightness (angina);
- pain that spreads to the neck, jaw, shoulders or arms;
- shortness of breath;
- unusual tiredness, feeling faint or feeling sick.
Chest pain that does not go away, or that comes on at rest, may be a heart attack: call the emergency number straight away.
How doctors find out
Your doctor asks about your symptoms, your family and your lifestyle, checks your blood pressure, and does blood tests for cholesterol and sugar. A risk score can estimate your chance of a heart attack or stroke in the next 10 years. Tests that can confirm it include an ECG, an echocardiogram, a chest X-ray, and a coronary angiogram, which is an X-ray that checks the blood vessels.
Current treatment
Treatment combines lifestyle changes with medicines such as blood thinners, statins and blood pressure medicines, and some people also need angioplasty with a stent or bypass surgery.
Will it get worse?
The symptoms can get worse over time as more fatty deposits build up. Over time it can lead to angina, a heart attack, heart failure or an irregular heartbeat. A healthy lifestyle may slow the disease down, and treatment can help reduce the chances of problems such as a heart attack.
Medicines: what helps, and what to watch for
Many different medicines are used to treat heart disease. Blood thinners such as low-dose aspirin or clopidogrel stop clots forming and lower the risk of a heart attack. Statins lower cholesterol. Beta blockers slow the heartbeat and help with angina. Nitrates widen the blood vessels and ease chest pain. Other medicines lower blood pressure.
Good to know:
- nitrates can cause mild headaches, dizziness and flushed skin;
- ACE inhibitors, such as ramipril, can cause a dry cough and dizziness, and you need regular blood tests to check your kidneys;
- calcium channel blockers can cause headaches and a flushed face, which are usually mild and short-lived.
Exercise and therapy help too
- cardiac rehabilitation after a heart attack: often weekly sessions that last 6 to 12 weeks, in a group, online or at home, with suitable exercise, advice on taking your medicines, stress management and support for anxiety and low mood;
- people who go to cardiac rehabilitation are less likely to have another heart attack or go into hospital;
- be active, eat a healthy, balanced diet and keep a healthy weight;
Procedures and surgery, for some people
In a coronary angioplasty, a small balloon pushes the fatty deposits outwards to widen a narrowed artery, and a small metal tube (stent) is usually left in to keep it open. It can be planned, or done urgently during a heart attack. In bypass surgery, a blood vessel is attached so that blood can flow around the narrowed or blocked part. Occasionally a heart transplant may be needed, when the heart is severely damaged and medicines do not work, or when the heart cannot pump enough blood.
Is there a cure?
No. Coronary heart disease cannot be cured, but treatment eases the symptoms and lowers the chance of a heart attack.
Sources
Written in plain words by Frontlight from these pages: